STERIS’ (TSE:STE – Free Report) – Raymond James issued their FY2027 earnings estimates for shares of STERIS’ in a report released on Wednesday, March 12th. Raymond James analyst M. Barth expects that the company will post earnings of $0.63 per share for the year. Raymond James also issued estimates for STERIS’’s FY2028 earnings at $0.66 EPS.
STE has been the topic of a number of other reports. Cormark raised STERIS’ to a “moderate buy” rating in a report on Monday, January 6th. Atb Cap Markets upgraded shares of STERIS’ to a “strong-buy” rating in a research note on Sunday, December 22nd.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- What Makes a Stock a Good Dividend Stock?
- Can TikTok Stock Picks Really Make You Rich?
- What is a Stock Market Index and How Do You Use Them?
- The “Quality” Rotation: Back to Basics Investing
- How is Compound Interest Calculated?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
